FRIDAY, June 6, 2025 (HealthDay News) — There’s a better option than daily aspirin to protect heart patients with a stent against dangerous blood clots, a new study found. A class of drugs called P2Y12 inhibitors that includes ticagrelor and clopidogrel could be more effective than low-dose aspirin in preventingContinue Reading

FRIDAY, June 6, 2025 (HealthDay News) — A repurposed diabetes drug can be an effective tool against fatty liver disease, a new clinical trial has found. Dapagliflozin helped people reduce fat levels in their liver and avoid liver scarring that comes with the condition, which doctors call metabolic dysfunction-associated steatohepatitis,Continue Reading